Randomized phase II trial of erlotinib (E) versus temozolomide (TMZ) or BCNU in recurrent glioblastoma multiforme (GBM): EORTC 26034

被引：0
|
作者：
Van den Bent, Martin [1 ]
Brandes, Alba
Rampling, Roy [2 ]
Kouwenhoven, Mathilde [3 ]
Kros, Johan M. [4 ]
Carpentier, Antoine [5 ]
Clement, Paul [6 ]
Klughammer, Barbara [7 ]
Bakker, Brenda [8 ]
Lacombe, Denis [9 ]
Gorlia, Thierry [9 ]
机构：
[1] Dr Daniel Den Hoed Canc Ctr, NL-3008 AE Rotterdam, Netherlands
[2] Beatson Oncol Ctr, Glasgow, Lanark, Scotland
[3] EEA, Rotterdam, Netherlands
[4] Erasmus MC, Rotterdam, Netherlands
[5] CHU Pitie Salpetriere, Paris, France
[6] Acad Ziekenhuis, Louvain, Belgium
[7] Hoffmann La Roche AG, Basel, Switzerland
[8] Erasme Univ Hosp, B-1070 Brussels, Belgium
[9] Eortc Data Ctr, Brussels, Belgium
来源：
NEURO-ONCOLOGY | 2007年 / 9卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：522 / 522
页数：1
相关论文
共 50 条
  • [31] PHASE II STUDY OF BEVACIZUMAB AND ERLOTINIB IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME
    Reardon, David A.
    Sathornsumetee, Sith
    Vredenburgh, James J.
    Rich, Jeremy N.
    Desjardins, Annick
    Quinn, Jennifer A.
    Mathe, Alyssa
    Gururangan, Sridharan
    Friedman, Allen H.
    Friedman, Henry S.
    NEURO-ONCOLOGY, 2009, 11 (02) : 231 - 231
  • [32] Phase I trial of erlotinib with radiation therapy (RT) in patients with glioblastoma multiforme (GBM)
    Krishnan, S
    Brown, P
    Ballman, K
    Fiveash, J
    Uhm, J
    Giannini, C
    Geoffroy, F
    Nabors, L
    Buckner, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 117S - 117S
  • [33] A RANDOMIZED PHASE II TRIAL OF VELIPARIB (V), RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) IN PATIENTS (PTS) WITH UNMETHYLATED MGMT (uMGMT) GLIOBLASTOMA (GBM): THE VERTU STUDY
    Khasraw, Mustafa
    McDonald, Kerrie Leanne
    Rosenthal, Mark
    Lwin, Zarnie
    Ashley, David
    Wheeler, Helen
    Barnes, Elizabeth
    Foote, Matthew
    Koh, Eng-Siew
    Sulman, Erik
    Back, Michael
    Buckland, Michael
    Sim, Hao-Wen
    Fisher, Lauren
    Leonard, Robyn
    Hall, Merryn
    Yip, Sonia
    Simes, John
    NEURO-ONCOLOGY, 2019, 21 : 18 - 18
  • [34] NUTMEG: A RANDOMISED PHASE II STUDY OF NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM): TRIAL IN PROGRESS
    Khasraw, Mustafa
    McDonald, Kerrie
    Yip, Sonia
    Verhaak, Roel
    Heimberger, Amy
    Hall, Merryn
    Fisher, Lauren
    Barnes, Elizabeth
    Rosenthal, Mark
    Gedye, Craig
    Hovey, Elizabeth
    Ellingson, Benjamin
    Simes, John
    Tognela, Annette
    Koh, Eng-Siew
    Gan, Hui
    Back, Michael
    Lwin, Zarnie
    NEURO-ONCOLOGY, 2018, 20 : 235 - 235
  • [35] Phase I/II study of enzastaurin (ENZ) plus temozolomide (TMZ) and radiation therapy (XRT) in patients with glioblastoma multiforme (GBM) or gliosarcoma (GS)
    Butowski, N. A.
    Lamborn, K.
    Chang, S.
    Page, M.
    Rabbitt, J.
    Fedoroff, A.
    Parvataneni, R.
    Nicol, S. J.
    Thornton, D.
    Prados, M. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] A phase I trial of gefitinib and sirolimus in adults with recurrent glioblastoma multiforme (GBM)
    Phuphanich, S.
    Rudnick, J.
    Chu, R.
    Yu, J. S.
    Black, K. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [37] A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy
    Raizer, Jeffrey J.
    Abrey, Lauren E.
    Lassman, Andrew B.
    Chang, Susan M.
    Lamborn, Kathleen R.
    Kuhn, John G.
    Yung, W. K. Alfred
    Gilbert, Mark R.
    Aldape, Kenneth A.
    Wen, Patrick Y.
    Fine, Howard A.
    Mehta, Minesh
    DeAngelis, Lisa M.
    Lieberman, Frank
    Cloughesy, Timothy F.
    Robins, H. Ian
    Dancey, Janet
    Prados, Michael D.
    NEURO-ONCOLOGY, 2010, 12 (01) : 95 - 103
  • [38] Multicenter Phase IB trial of carboxyamidotriazole orotate (CTO) combined with temozolomide (TMZ) for recurrent glioblastoma (GBM) and other malignant gliomas (MG).
    Lin, Xuling
    Kaley, Thomas Joseph
    Pentsova, Elena
    DeAngelis, Lisa Marie
    Daras, Mariza
    Gavrilovic, Igor T.
    Mellinghoff, Ingo K.
    McKeown, Andrew
    Manne, Malbora
    Hansen, Jessica
    Bavisotto, Linda M.
    Gorman, Greg
    Lamson, Michael
    Karmali, Rashida A.
    Omuro, Antonio Marcilio Padula
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [39] Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme
    Groves, MD
    Puduvalli, VK
    Hess, KR
    Jaeckle, KA
    Peterson, P
    Yung, WKA
    Levin, VA
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) : 1383 - 1388
  • [40] Phase II study of combination carboplatin and erlotinib in patients with recurrent glioblastoma multiforme
    De Groot, J. F.
    Gilbert, M. R.
    Hess, K. R.
    Hanna, T.
    Groves, M.
    Conrad, C.
    Aldape, K.
    Colman, H.
    Puduvalli, V.
    Yung, W. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345